B=Black 28.0, W=White 19.9, NA=Native American 17.8, H=Hispanic 13.7, A=Asian/Pacific Islander 11.7 Source: National Cancer Institute Cancer Stat Facts: Female Breast Cancer More about breast cancer disparities
Hispanic women had the lowest five-year survival from Triple Negative Breast Cancer (TNBC) at 10.7%, compared to Black women at 11.8% and White women at 13.1%, in a study of 26,963 women diagnosed with TNBC between 2010 and 2016. Higher proportions of Hispanic (16.8%) and Black women (9.0%) were diagnosed with TNBC before the age
Despite the practical benefits of computed tomography colonography (CTC) for colorectal cancer screening and its endorsement by multiple organizations, the federal government’s Centers for Medicare and Medicaid Services has declined to cover this procedure by Medicare and Medicaid. A recent analysis of health interviews with nearly 14,000 Americans found that Blacks and Hispanics were nearly
Government declines to cover colorectal screening method favored by Blacks and Hispanics Read More »
Black patients with multiple myeloma waited an average of four months longer than White patients for a hematopoietic stem cell transplant, according to a study of 495 patients treated by the Moffitt Cancer Center inf Florida. The transplant is an infusion of healthy stem cells after chemotherapy to reestablish the blood cell production process in
Black patients with multiple myeloma wait longer than White patients for transplants Read More »
Approval of immunotherapy for advanced lung cancer by the Food and Drug Administration (FDA) led to a significant increase in its use, but this did not eliminate disparities among users that were apparent prior to approval. The FDA approval process typically takes around 7 years, but clinical trials, compassionate use, and other agreements mean that
Colorectal cancer screening prevalence remained low in 2018 among U.S. adults aged 50 to 54 years, especially among Hispanics and Asians. Screening guidelines recently changed to recommend starting at age 45 for those with an average risk of the cancer. “To anticipate some of the challenges implementing screening programs, we examined patterns of screening among
Colorectal cancer screening rate low among Hispanics and Asian Americans aged 50 to 54 Read More »
Black and Asian women are more likely than White women to experience significant delays in getting breast biopsies after their mammogram identifies an abnormality, according to a new review of more than 45,000 women’s cases. At 90 days from their mammograms, the risk of not undergoing a biopsy compared with White women was 28 percent
Endometrial cancer was long believed to be less common among Black women. But newer studies have confirmed that it is not only more likely to strike Black women but also more likely to be deadly. Black women die of uterine (endometrial) cancer at twice the rate of white women, according to a new report. The gap
Endometrial cancer on the rise, especially among Black women Read More »
The high burden of breast cancer mortality in African American women versus White women began in the United States in the 1980’s, according to a history co-written by Hyuna Sung (above) of the American Cancer Society. At that time, breast cancer screening with mammography and treatments such as adjuvant post-surgery hormonal therapy were disseminated widely
Higher breast cancer mortality for Black women emerged 40 years ago Read More »
Preoperative MRI leads to better outcomes after prostate cancer surgery, but Black and Hispanic men are less likely than White men to receive it, according to a new study led by Alexander Cole, MD, of Brigham and Women’s Hospital in Boston. Cole and his colleagues analyzed the medical records of more than 19,000 men, average
Black and Hispanic men less likely to get helpful MRI before prostate cancer surgery Read More »
Information provided on this website is neither intended nor implied to be a substitute for professional medical advice and is not intended to replace the services of a physician.
You should not use information on this web site or the information on links from this site to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider.
